The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis
Abstract
OBJECTIVES: To determine whether patients with myasthenia gravis (MG) have serum antibodies to lipoprotein-related protein 4 (LRP4), a newly identified receptor for agrin that is essential for neuromuscular junction formation, and to establish whether such antibodies contribute to MG pathogenesis. DESIGN: Serum samples from patients with MG with known status of serum antibodies to the acetylcholine receptor (AChR) and muscle-specific kinase (MuSK) and serum samples from control subjects (healthy individuals and individuals with other diseases) were tested for antibodies to LRP4. Serum samples with such antibodies were tested to determine whether they had the ability to inhibit 2 different functions of LRP4 at the neuromuscular junction. SETTING: Serum samples were collected at the Hellenic Pasteur Institute and Wayne State University. Samples were tested for LRP4 autoantibodies at Georgia Health Sciences University. Other immunoreactivities of the samples were tested at the Hellenic Pasteur Institute, Athens, Greece, or processed through University Laboratories of the Detroit Medical Center, Michigan. Patients The study included 217 patients with MG, 76 patients with other neurologic or psychiatric diseases, and 45 healthy control subjects. RESULTS: Anti-LRP4 antibodies were detected in 11 of 120 patients with MG without detectable anti-AChR or anti-MuSK antibodies (double seronegative) and in 1 of 36 patients without anti-AChR antibodies but with anti-MuSK antibodies, but they were not detected in any of the 61 patients with anti-AChR antibodies. No healthy control subjects and only 2 of the 76 control patients with neurologic disease had anti-LRP4 antibodies. Serum samples from patients with MG with anti-LRP4 antibodies were able to inhibit the LRP4-agrin interaction and/or alter AChR clustering in muscle cells. CONCLUSIONS: Anti-LRP4 antibodies were detected in the serum of approximately 9.2% of patients with double-seronegative MG. This frequency is intermediate compared with 2 recent studies showing anti-LRP4 antibodies in 2% and 50% of patients with double-seronegative MG from different geographic locations. Together, these observations indicate that LRP4 is another autoantigen in patients with MG, and anti-LRP4 autoantibodies may be pathogenic through different immunopathogenic processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoch, W., McConville, J., Helms, S., Newsom-Davis, J., Melms, A., & Vincent, A. (2001) · Nature Medicine · doi:10.1038/85520 · Cited by 1,183
Autoimmune Response to Acetylcholine Receptor
Patrick, J., & Lindstrom, J. (1973) · Science · doi:10.1126/science.180.4088.871 · Cited by 1,043
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
Meriggioli, M. N., & Sanders, D. B. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70063-8 · Cited by 894
Lrp4 is a receptor for Agrin and forms a complex with MuSK
Kim, N., Stiegler, A. L., Cameron, T. O., Hallock, P. T., Gomez, A. M., Huang, J. H., Hubbard, S. R., Dustin, M. L., & Burden, S. J. (2008) · Cell · doi:10.1016/j.cell.2008.10.002 · Cited by 676
Neuromyelitis Optica and Non–Organ-Specific Autoimmunity
Pittock, S. J., Lennon, V. A., de Seze, J., Vermersch, P., Homburger, H. A., Wingerchuk, D. M., Lucchinetti, C. F., Zéphir, H., Moder, K., & Weinshenker, B. G. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.17 · Cited by 608
Autoantibodies to low‐density lipoprotein receptor–related protein 4 in myasthenia gravis
Higuchi, O., Hamuro, J., Motomura, M., & Yamanashi, Y. (2011) · Annals of Neurology · doi:10.1002/ana.22312 · Cited by 535
IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†
Leite, M. I., Jacob, S., Viegas, S., Cossins, J., Clover, L., Morgan, B. P., Beeson, D., Willcox, N., & Vincent, A. (2008) · Brain · doi:10.1093/brain/awn092 · Cited by 527
LRP4 serves as a coreceptor of Agrin
Zhang, B., Luo, S., Wang, Q., Suzuki, T., Xiong, W. C., & Mei, L. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.006 · Cited by 525
To build a synapse: signaling pathways in neuromuscular junction assembly
Wu, H., Xiong, W. C., & Mei, L. (2010) · Development · doi:10.1242/dev.038711 · Cited by 519
Myasthenia Gravis: Study of Humoral Immune Mechanisms by Passive Transfer to Mice
Toyka, K. V., Drachman, D. B., Griffin, D. E., Pestronk, A., Winkelstein, J. A., Fischbeck, K. H., & Kao, I. (1977) · New England Journal of Medicine · doi:10.1056/nejm197701202960301 · Cited by 436
Clinical aspects of MuSK antibody positive seronegative MG
Sanders, D. B., El-Salem, K., Massey, J. M., McConville, J., & Vincent, A. (2003) · Neurology · doi:10.1212/01.wnl.0000065882.63904.53 · Cited by 407
LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction
Weatherbee, S. D., Anderson, K. V., & Niswander, L. A. (2006) · Development · doi:10.1242/dev.02696 · Cited by 351
[29] Production and assay of antibodies to acetylcholine receptors
Lindstrom, J., Einarson, B., & Tzartos, S. (1981) · Methods in Enzymology · doi:10.1016/0076-6879(81)74031-x · Cited by 268
The Epidemiology of Myasthenia Gravis
PHILLIPS, L. H. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1254.053 · Cited by 250
Anti‐MuSK patient antibodies disrupt the mouse neuromuscular junction
Cole, R. N., Reddel, S. W., Gervásio, O. L., & Phillips, W. D. (2008) · Annals of Neurology · doi:10.1002/ana.21371 · Cited by 174
McKeon, A. B., Lennon, V. A., Jacob, A., Matiello, M., Lucchinetti, C. F., Kale, N., Chan, K. H., Weinshenker, B. G., Apiwattinakul, M., Wingerchuk, D. M., et al. (2008) · Muscle & Nerve · doi:10.1002/mus.21197 · Cited by 148
Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice
Johnson, E. B., Hammer, R. E., & Herz, J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi381 · Cited by 141
Jha, S., Xu, K., Maruta, T., Oshima, M., Mosier, D. R., Atassi, M. Z., & Hoch, W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.016 · Cited by 108
Cole, R. N., Ghazanfari, N., Ngo, S. T., Gervásio, O., Reddel, S., & Phillips, W. D. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.190298 · Cited by 103
Zhang, B., Luo, S., Dong, X., Zhang, X., Liu, C., Luo, Z., Xiong, W., & Mei, L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4691-06.2007 · Cited by 102
Engel, A. G., Tsujihata, M., Lambert, E. H., Lindstrom, J. M., & Lennon, V. A. (1976) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-197609000-00008 · Cited by 97
Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice
Punga, A. R., Lin, S., Oliveri, F., Meinen, S., & Rüegg, M. A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.04.018 · Cited by 90
Hopf, C., & Hoch, W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6467 · Cited by 87
HSP90β Regulates Rapsyn Turnover and Subsequent AChR Cluster Formation and Maintenance
Luo, S., Zhang, B., Dong, X., Tao, Y., Ting, A. K. L., Zhou, Z., Meixiong, J., Luo, J., Chiu, F., Xiong, W., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.08.013 · Cited by 85
Antibody-induced dimerization activates the epidermal growth factor receptor tyrosine kinase
Spaargaren, M., Defize, L. H., Boonstra, J., & de Laat, S. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52357-7 · Cited by 70
Tian, Q., Suzuki, T., Yamauchi, T., Sakagami, H., Yoshimura, Y., Miyazawa, S., Nakayama, K., Saitoh, F., Zhang, J., Lu, Y., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04846.x · Cited by 58
ter Beek, W. P., Martínez‐Martínez, P., Losen, M. H., Baets, M. H. D., Wintzen, A. R., Verschuuren, J. J. G. M., Niks, E. H., van Duinen, S. G., Vincent, A. C., & Molenaar, P. C. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090040 · Cited by 40
Occurrence of CNS demyelinating disease in patients with myasthenia gravis
Weinshenker, B. G., Jacob, A., Kister, I., Herbert, J., Swerdlow, M. L., Bergamaschi, R., Piccolo, G., & Oger, J. (2007) · Neurology · doi:10.1212/01.wnl.0000262954.51568.25 · Cited by 37
Myasthenia Gravis Experimentally Induced with Muscle‐specific Kinase
Shigemoto, K., Kubo, S., Jie, C., Hato, N., Abe, Y., Ueda, N., Kobayashi, N., Kameda, K., Mominoki, K., Miyazawa, A., et al. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1405.002 · Cited by 29
Hamnik, S. E., Hacein‐Bey, L., Biller, J., Gruener, G., & Jay, W. M. (2008) · Seminars in Ophthalmology · doi:10.1080/08820530802049921 · Cited by 19
Cited by
Myasthenia gravis: subgroup classification and therapeutic strategies
Gilhus, N. E., & Verschuuren, J. J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00145-3 · Cited by 1,267
Gilhus, N. E. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1602678 · Cited by 1,048
Gilhus, N. E., Tzartos, S., Evoli, A., Palace, J., Burns, T. M., & Verschuuren, J. J. G. M. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0079-y · Cited by 953
Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations
Dresser, L., Wlodarski, R., Rezania, K., & Soliven, B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112235 · Cited by 475
Mechanisms Regulating Neuromuscular Junction Development and Function and Causes of Muscle Wasting
Tintignac, L. A., Brenner, H.-R., & Rüegg, M. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00033.2014 · Cited by 422
Metadata
- Authors
- Tzartos, J. S.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2012-04-01
- Volume
- 69
- Issue
- 4
- Pages
- 445
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2111821994
- Cited by
- 342
- References
- 30
- FWCI
- 14.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.